packageSavolitinib

savolitinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Savolitinib is an investigational anticancer drug, a c-MET kinase inhibitor being studied as a protein kinase inhibitor for treating cancer. It is not yet an approved medicine and has no marketing authorisation in the European Union; it remains under clinical investigation.

Summary written by glm-5.3-flash from Wikidata Q27254463 and the WHO ATC classification; not checked by a person.

name:savolitinib
ATC codes:L01EP03
DrugBank:DB12048
PubChem CID:68289010
Wikidata:Q27254463
formula:C17H15N9
molar mass:345.37 g/mol (PubChem CID 68289010)

Metabolites

AZ5104AZ5104485.592 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
AZ5104metabolite: AZ5104